EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway

Zhan Zhou, Ying Yang, Yi Wei, Yubo Xie

Neurochemical Research · 2024-05 · 49 (5) · 1306-1321

DOI: 10.1007/s11064-024-04115-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 12.03.2024. Verfasst von Zhan Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China. Hauptthemen laut MEDLINE: Sepsis, Cognitive Dysfunction. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Fund of Neurotoxicity of General Anesthetics and Its Prevention and Treatment Innovation Team of the First Affiliated Hospital of Guangxi Medical Unive…, Guangxi Clinical Research Center for Anesthesiology, the Key Project of Natural Science Foundation of Guangxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis-induced neuroinflammation is significantly associated with sepsis-related brain dysfunction. Remimazolam is a novel ultra-short-acting benzodiazepine anesthetic with multiple organ protective effects. However, it is unknown whether remimazolam can ameliorate LPS-induced brain impairment. In this study, Lipopolysaccharide (5 mg/kg, LPS) severely impaired Sprague-Dawley rats spatial learning ability, memory, and cognitive function. However, remimazolam treatment showed a protective effect on LPS-induced cognitive dysfunction. Remimazolam partly reversed LPS-induced splenomegaly, decreased serum cytokine expression, suppressed hippocampal M1 microglial activation, and mitigated oxidative stress injury and neuroinflammation. Electroacupuncture (EA) or PNU282987 treatment improved LPS-induced cognitive dysfunction and also significantly inhibited neuroinflammation and systemic inflammation. However, MLA, ML385, or subdiaphragmatic vagus nerve (SDV) treatment abolished the protective effects of remimazolam. Further mechanistic studies showed that remimazolam induces protective effects by activating subdiaphragmatic vagus nerve target α7nAChR-mediated Nrf2/HO-1 signaling pathway. These results demonstrate that remimazolam can up-regulate α7nAChR, Cyto-Nrf2, HO-1, and cognitive-related (CREB, BDNF, PSD95) protein expressions, suppress M1 microglia, ameliorate neuroinflammation or systemic inflammation, and reverse cognitive dysfunction. Therefore, this study provides insight into a new therapeutic target for the treatment of sepsis-induced cerebral dysfunction. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisCognitive DysfunctionRatsAnimalsRats, Sprague-DawleyLipopolysaccharidesalpha7 Nicotinic Acetylcholine ReceptorNF-E2-Related Factor 2Neuroinflammatory DiseasesSignal TransductionBenzodiazepinesInflammationVagus Nerve

Stichwörter der Autor:innen

Cognitive dysfunctionLipopolysaccharideMicrogliaNeuroinflammationRemimazolam

Substanzen

Lipopolysaccharidesalpha7 Nicotinic Acetylcholine ReceptorNF-E2-Related Factor 2remimazolamBenzodiazepines

Autor:innen und Institutionen

  • Department of Anesthesiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
  • Department of Anesthesiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China. xybdoctor@163.com.
  • Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China. xybdoctor@163.com.

Förderung

  • Special Fund of Neurotoxicity of General Anesthetics and Its Prevention and Treatment Innovation Team of the First Affiliated Hospital of Guangxi Medical Unive…
  • Guangxi Clinical Research Center for Anesthesiology
  • the Key Project of Natural Science Foundation of Guangxi

Zitieren

APA

Zhou, Z., Yang, Y., Wei, Y., & Xie, Y. (2024). Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway. Neurochemical Research, 49(5), 1306-1321. https://doi.org/10.1007/s11064-024-04115-x

Vancouver

Zhou Z, Yang Y, Wei Y, Xie Y. Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway. Neurochemical Research. 2024;49(5):1306-1321. doi:10.1007/s11064-024-04115-x

BibTeX
@article{Zhou2024,
  author = {Zhou, Zhan and Yang, Ying and Wei, Yi and Xie, Yubo},
  title = {Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway},
  journal = {Neurochemical Research},
  year = {2024},
  volume = {49},
  number = {5},
  pages = {1306--1321},
  doi = {10.1007/s11064-024-04115-x}
}
Kostenlos starten →